AI Should Strengthen Trial Execution, Not Substitute For It

A STRATEGIC LAYER

Our view on AI in clinical trials

The conversation around live clinical trials has shifted. The central question is no longer whether continuous, live trial models are possible, but how they can be made trustworthy, explainable, and operationally sound. Regulatory thinking is increasingly focused on earlier signal detection, continuous data review, and the responsible use of AI in settings where quality, safety, and auditability are non-negotiable. Against that backdrop, TruTechnologies takes a deliberate view. AI is not a slogan, and it is not the foundation of trial delivery. It is a strategic layer applied to robust operational processes that already support reliable execution. That distinction matters.

THE FOUNDATION COMES FIRST

Strong execution before intelligent automation

Real-time trials depend on far more than analytics. They require dependable data capture, integrated workflows, and rigorous validation across the operational chain. TruTechnologies delivers live trial capability through that foundation first. AI is then used to accelerate interpretation, support better decisions, and improve response times. This is an important strategic principle: AI should sit above a strong execution and integration layer, not attempt to compensate for its absence.

ALIGNED WITH THE DIRECTION OF REGULATION

Innovation only becomes valuable when it can be trusted.

In high-stakes clinical environments, AI outputs must be explainable, auditable, and grounded in high-integrity data. Speed alone is not enough. TruTechnologies' position is clear: the future of live trials will belong not to the loudest AI claims, but to the platforms that combine operational discipline with intelligent, accountable augmentation.

Where AI creates value

Enhancing the quality and responsiveness of live trials.

In the TruTechnologies model, AI is used to help teams act faster and with more confidence — not to replace the judgement of the people running the trial.

• Prioritized monitoring

Directly monitor activity where risk, variability, or emerging issues require faster attention.

• Earlier signal detection

Surface anomalies in live data streams so potential concerns can be identified earlier.

• Workflow optimization

Streamline fragmented operational processes across sponsors, sites and labs.

• Site performance

Improve site performance through timely visibility and well-targeted intervention.